Credit: iStock.com/baytunc
Paul Weiss ordered to reveal privileged information from investigation on behalf of bankrupt Chinese medical company
01 October 2015
A US court has demanded that Paul Weiss Rifkind Wharton & Garrison hand over privileged information from an internal investigation the law firm oversaw for China Medical Technologies (CMED) to the company’s liquidator.
Credit: iStock.com/baytunc
Related
-
US: New Strategies for Getting Paid: Recent Investment Fund Activity in Chapter 11
-
UK director’s extradition to Italy on bankruptcy fraud charges delayed
-
São Paulo firm says Avianca creditor stay may breach Cape Town treaty
-
Steinhoff adds Lehman administrator as €12bn class action looms
-
Guitar maker’s German supplier says GDPR will cause US discovery delay
Most Read
- BDO appointed as administrators of collapsed airline flybmi
- Duff & Phelps expands in Asia with Zolfo Cooper acquisition
- Hyflux plan raises transparency questions in Singapore
- China’s “lack of experienced experts” spurs new Shanghai advisory firm
- Puerto Rico oversight board picks unconstitutional, appeals court finds
